Blacksmith Medicines
Pre-clinicalPurpose-Built Platform for Metalloenzyme-Targeted Medicines Purpose-Built Platform for Human Metalloenzyme-Targeted Medicines
Founded
2019
Focus
Small Molecules
About
Purpose-Built Platform for Metalloenzyme-Targeted Medicines Purpose-Built Platform for Human Metalloenzyme-Targeted Medicines
Funding History
4Total raised: $175.0M
Series B$75MMPM CapitalMar 15, 2022
Series A$50MNovartis Venture FundOct 15, 2020
Series A$50MNovartis Venture FundJun 15, 2020
Grant$15KNIEHSJul 10, 2014
Company Info
TypePrivate
Founded2019
LocationSan Francisco, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile